InMed Pharmaceuticals (INM) Non-cash Items (2023 - 2026)

InMed Pharmaceuticals has reported Non-cash Items for 4 years, with the latest figure at $109344.0 in Q1 2026.

• For the quarter ending Q1 2026, Non-cash Items rose 10.44% year-over-year to $109344.0; the trailing twelve-month figure through Mar 2026 stood at $109344.0 (up 10.44% YoY), and the FY2025 full-year result was $72549.0, down 60.69% from the prior year.
• Non-cash Items for Q1 2026 stood at $109344.0, down from $161372.0 in the prior quarter.
• The five-year high for Non-cash Items was $187634.0 in Q4 2023, with the low at $50055.0 in Q3 2025.
• Historically, Non-cash Items has averaged $116172.6 across 4 years, with a median of $109344.0 in 2026.
• Annual changes were most pronounced in 2024 — Non-cash Items jumped 53.07% — and 2025, when it sank 60.69%.
• InMed Pharmaceuticals' Non-cash Items stood at $187634.0 in 2023, then dropped by 27.04% to $136899.0 in 2024, then gained by 17.88% to $161372.0 in 2025, then slumped by 32.24% to $109344.0 in 2026.
• The last three Non-cash Items figures came in at $109344.0 (Q1 2026), $161372.0 (Q4 2025), and $50055.0 (Q3 2025), per Business Quant data.